The $195 Million Voucher: How Denali Turned a Hunter Syndrome Approval Into a Pipeline War Chest
Denali's $195M PRV sale after AVLAYAH's March 2026 FDA approval reveals how rare disease wins now fund the next...
Blood-Brain Barrier
Denali's $195M PRV sale after AVLAYAH's March 2026 FDA approval reveals how rare disease wins now fund the next...